1-3 of 3
Olivier Loria
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab® and High Dose Methylprednisolone (HDMP) as a First Line Treatment for Patients with Chronic Lymphocytic Leukemia.

Januario E. Castro, MD, Jan E. Bole, R.N., Carlos E. Prada, MD, Olivier Loria, BS, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2969.
https://doi.org/10.1182/blood.V106.11.2969.2969
Published: 2005
Journal Articles

ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia

Januario E. Castro, Carlos E. Prada, Olivier Loria, Adeela Kamal, Liguang Chen, Francis J. Burrows, Thomas J. Kipps
Journal: Blood
Blood (2005) 106 (7): 2506–2512.
https://doi.org/10.1182/blood-2005-03-1099
Published: 2005
Journal Articles

ZAP-70 Expressed in CLL Is an Hsp90 Client Protein and Its Level of Expression Can Be Downregulated by Specific Hsp90 Inhibitors.

Carlos E. Prada, M.D., Olivier Loria, Adeela Kamal, Ph.D., Francis J. Burrows, Ph.D., Thomas J. Kipps, M.D., Ph.D., Januario E. Castro, M.D.
Journal: Blood
Blood (2004) 104 (11): 2803.
https://doi.org/10.1182/blood.V104.11.2803.2803
Published: 2004